Resources>Upcoming Events>The 4th Fc-Mediated Function Summit

The 4th Fc-Mediated Function Summit

Biointron 2024-03-20

Fc-Mediated-2024.jpg

Biointron is thrilled to be part of the 4th Fc-Mediated Function Summit, a pivotal event focusing on the latest developments in FcRn, FcγR, and IgG, aiming to enhance related therapeutic applications. This unique conference, happening in Boston from April 16-18, 2024, will be gathering over 80 specialists in the field to share insights on molecular engineering and clinical outcomes.

The summit offers an exclusive platform for networking with experts and peers, presenting an opportunity to discuss the newest research and trends in the industry. Attendees can expect to engage in meaningful discussions, expanding their knowledge and contributing to the advancement of therapeutic solutions.

For those interested in attending or learning more about the event's comprehensive agenda, we encourage visiting the conference website for more details and registration information. Don't miss this chance to connect with leaders in the field and explore the cutting-edge of Fc-mediated function research.

Biointron is excited to announce that we will be attending the 4th Fc-Mediated Function Summit in 2024. Our team is looking forward to engaging in meaningful discussions, sharing our insights, and exploring collaborative opportunities with fellow industry experts!

For more information about the 4th Fc-Mediated Function Summit, please visit: [https://fc-function-summit.com/]

Time: April 16-18, 2024

Location: Boston, MA

Subscribe to our Upcoming Events
Explore More Events
BIO Korea 2026

Time: April 28 – 30, 2026
Location: Seoul, South Korea
Booth: #B31

Immunology 2026

Time: April 15 - 19, 2026
Location: Boston, MA
Booth: #1228

Antibody Therapeutics Conference Taiwan 2026

Time: May 26 - 27, 2026
Location: Taipei, Taiwan

CHABS 2026 Annual Conference

Time: May 9 - 10, 2026
Location: Boston, MA

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.